Serial 79443595
Live / Registered — Registered (as of 01 Sept 2026)
What this means for you
Registered since 01 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Sept 2032: the §71 affidavit of use).
Record
- Serial number
- 79443595
- Registration number
- 8418452
- Mark type
- Design / logo
- Filed
- 25 Nov 2025
- Published for opposition
- 14 Jul 2026
- Registered
- 01 Sept 2026
- Next maintenance filing
- §71 affidavit of use, due by 01 Sept 2032 (grace period to 01 Mar 2033)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Novartis Pharma AG, CH
- Novartis Pharma AG, CH
- Novartis Pharma AG, CH
Prosecution history
- 01 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Jun 2026 — REFUSAL PROCESSED BY IB
- 16 May 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 16 May 2026 — REFUSAL PROCESSED BY MPU
- 31 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 31 Mar 2026 — NON-FINAL ACTION WRITTEN
- 30 Mar 2026 — ASSIGNED TO EXAMINER